JPMorgan Chase unveils new Sapphire Reserve card perks and $795 annual fee

JPMorgan Chase unveils new Sapphire Reserve card perks and 5 annual fee


Key Points
  • JPMorgan Chase is betting that a long list of new perks will keep affluent Americans hooked on its Sapphire Reserve card, despite a hefty bump in its annual fee.
  • The bank on Tuesday unveiled an update to its premium credit card, which will now carry a $795 annual fee.
  • The bank is touting a new redemption program that doubles the value of points used for select travel offers and a new $500 annual credit at its collection of hotels and resorts, alongside other new benefits.



Source

Stocks making the biggest moves midday: Jabil, JetBlue, Sunrun, Valero, Verve Therapeutics and more
Finance

Stocks making the biggest moves midday: Jabil, JetBlue, Sunrun, Valero, Verve Therapeutics and more

These are some of the stocks posting the biggest moves in midday trading. Jabil – The electronic manufacturing company and supplier to Apple surged nearly 12%. Jabil lifted its full-year guidance, calling for core earnings of $9.33 per share and net revenue of $29 billion. The company also posted top and bottom line beats in […]

Read More
Stocks making the biggest moves premarket: Sunrun, Verve Therapeutics, T-Mobile and more
Finance

Stocks making the biggest moves premarket: Sunrun, Verve Therapeutics, T-Mobile and more

Check out the companies making headlines before the bell. Solar stocks — Companies in the space got battered as the Senate’s version of President Trump’s tax bill would phase out renewable energy incentives . Shares of Enphase Energy dropped 20%, while First Solar and Sunrun slid 16% and 36%, respectively. SolarEdge Technologies pulled back 30%. […]

Read More
Nasdaq-traded Chinese herb company hits near  billion market value after speculative surge
Finance

Nasdaq-traded Chinese herb company hits near $30 billion market value after speculative surge

Key Points Shares of Regencell Bioscience, a Hong Kong-based developer of traditional Chinese herbal treatments that it says can treat childhood ADHD and autism, more than tripled Monday. The stock soared more than 280% after a 38-for-1 stock split. The company, which has no revenue, is up roughly 46,000% in 2025. On Monday, one social […]

Read More